PRESS RELEASE published on 02/02/2026 at 16:05, 7 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Glencore plc The Vanguard Group, Inc. discloses ownership of 4.88% in Glencore plc. Details on positions, dealings, and other relevant information provided in Form 8.3 Form 8.3 The Vanguard Group Ownership Disclosure Financial Disclosure Glencore Plc
BRIEF published on 02/02/2026 at 16:04, 7 months 28 days ago The Vanguard Group Discloses Position in Just Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group Just Group
BRIEF published on 02/02/2026 at 16:04, 7 months 28 days ago Le groupe Vanguard révèle sa participation dans Just Group plc Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Information Sur Les Valeurs Mobilières Groupe Just
BRIEF published on 02/02/2026 at 16:03, 7 months 28 days ago Vanguard Group Discloses Position in Picton Property Income Securities Disclosure Vanguard Group Inc. Takeover Code Picton Property Income
BRIEF published on 02/02/2026 at 16:03, 7 months 28 days ago Le groupe Vanguard révèle sa position dans Picton Property Income Titres Code De Prise De Contrôle Divulgation Groupe Vanguard Inc. Revenus Fonciers De Picton
PRESS RELEASE published on 02/02/2026 at 16:03, 7 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses 5.94% stake in Avadel Pharmaceuticals plc as of 30th Jan 2026. Form 8.3 filed with Irish Takeover Panel The Vanguard Group, Inc. Form 8.3 Irish Takeover Panel Stake Disclosure Avadel Pharmaceuticals Plc
BRIEF published on 02/02/2026 at 16:03, 7 months 28 days ago Vanguard Group Discloses Position in NCC Group plc Form 8.3 Takeover Code Securities Disclosure Vanguard Group NCC Group
BRIEF published on 02/02/2026 at 16:03, 7 months 28 days ago Vanguard Group révèle sa participation dans NCC Group plc Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Groupe NCC Informations Sur Les Valeurs Mobilières
PRESS RELEASE published on 02/02/2026 at 16:02, 7 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.02% interest in Beazley plc's 5p ordinary shares as of 30 Jan 2026. Purchased additional securities on 02 Feb 2026 Securities Disclosure The Vanguard Group Beazley Plc 5.02%
PRESS RELEASE published on 02/02/2026 at 16:01, 7 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.58% stake in Spire Healthcare Group plc as of 30 January 2026. Details in Form 8.3 according to the Takeover Code Form 8.3 Takeover Code Vanguard Group Spire Healthcare Stake Disclosure
Published on 09/30/2026 at 23:30, 7 minutes ago Early Warning News Release Issued with Respect to the Acquisition of Securities of Cypher Metaverse Inc.
Published on 09/30/2026 at 20:35, 3 hours 2 minutes ago Fairplay Ventures Inc. Enters Into Definitive Agreement to Complete Qualifying Transaction With Ampere Metals Pty. Limited
Published on 09/30/2026 at 15:50, 7 hours 47 minutes ago Innodata Opens Motion-Capture AI Lab to Help Humanoids Move Like Humans
Published on 09/30/2026 at 14:37, 9 hours ago NuRAN Leverages Starlink Backhaul to Drive Higher Revenue Per Rural Site
Published on 09/30/2026 at 14:31, 9 hours 6 minutes ago First Breach Expands Ammunition Manufacturing Operations to Seven Days a Week
Published on 09/30/2026 at 23:23, 14 minutes ago LM PAY S.A. publishes audited FY 2025 results: EBIT reaches PLN 12.4 million and exceeds preliminary result and guidance
Published on 09/30/2026 at 22:34, 1 hour 3 minutes ago The Change of Date of the Annual Report 2025 Publication
Published on 09/30/2026 at 22:05, 1 hour 32 minutes ago ADS-TEC Energy Reports First Half 2026 Results; Advances Gigawatt-Scale SKM Storage Project and Strengthens its Position to Scale Own & Operate Model
Published on 09/30/2026 at 22:05, 1 hour 32 minutes ago Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
Published on 09/30/2026 at 22:05, 1 hour 32 minutes ago Abivax présentera des données sur l’obéfazimod lors de l’United European Gastroenterology (UEG) Week 2026
Published on 09/30/2026 at 18:44, 4 hours 52 minutes ago Broadcast of the 5th edition of “On the way up”
Published on 09/30/2026 at 18:44, 4 hours 52 minutes ago Diffusion de la 5e édition de “On the way up”
Published on 09/30/2026 at 18:18, 5 hours 19 minutes ago Nombre total de droits de vote et d'actions composant le capital social
Published on 09/30/2026 at 18:15, 5 hours 22 minutes ago The Belgian State and ENGIE Group have agreed to extend the target date for concluding the Heads of Terms until 4 november 2026
Published on 09/30/2026 at 18:15, 5 hours 22 minutes ago L’État belge et le groupe ENGIE ont convenu de reporter au 4 novembre 2026 la date cible pour la conclusion des Heads of Terms
